IRIS
VENERITO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.366
EU - Europa 335
AS - Asia 76
OC - Oceania 2
SA - Sud America 2
Totale 1.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.364
SE - Svezia 150
IT - Italia 82
CN - Cina 46
FR - Francia 33
GB - Regno Unito 23
DE - Germania 17
IN - India 16
BE - Belgio 12
UA - Ucraina 6
FI - Finlandia 4
IR - Iran 4
VN - Vietnam 4
ID - Indonesia 3
AU - Australia 2
BR - Brasile 2
CA - Canada 2
PT - Portogallo 2
AT - Austria 1
ES - Italia 1
HR - Croazia 1
IE - Irlanda 1
IS - Islanda 1
JP - Giappone 1
RO - Romania 1
SG - Singapore 1
TW - Taiwan 1
Totale 1.781
Salva come PNG Salva come JPEG
Città #
Chandler 198
Fairfield 183
Nyköping 136
Ashburn 114
Woodbridge 81
Houston 74
Cambridge 71
Seattle 65
Wilmington 49
Ann Arbor 43
New York 33
Lawrence 32
Roxbury 30
Bari 26
Beijing 25
Inglewood 25
Jacksonville 21
Des Moines 19
Pune 14
Brussels 12
San Diego 9
Nanjing 7
Paris 6
Redwood City 6
Brindisi 5
London 5
Shenyang 5
Brooklyn 4
Dearborn 4
Dong Ket 4
Helsinki 4
Hounslow 4
Los Angeles 4
Ardabil 3
Florence 3
Milan 3
New Bedfont 3
Ostwald 3
Princeton 3
San Francisco 3
Tianjin 3
Washington 3
Augusta 2
Avegno 2
Hefei 2
Leawood 2
Massa 2
Melbourne 2
Prescot 2
San Mateo 2
Toronto 2
Bitonto 1
Boardman 1
Cerignola 1
Chapel Hill 1
Chiswick 1
Dallas 1
Dublin 1
Giovinazzo 1
Haikou 1
Harbin 1
Hebei 1
Jakarta 1
Kilburn 1
Madrid 1
Marseille 1
Monmouth Junction 1
Mountain View 1
Mumbai 1
Nagold 1
Norwalk 1
Oklahoma City 1
Reykjavik 1
Rome 1
Southwark 1
Taipei 1
Taranto 1
Vienna 1
Wandsworth 1
Totale 1.391
Salva come PNG Salva come JPEG
Nome #
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 104
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 101
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 101
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 96
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 84
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 77
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 75
null 71
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 65
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 64
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 58
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 56
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 46
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 45
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 43
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis 42
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 42
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 39
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 38
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 38
A machine learning tool to predict the response to neoadjuvant chemotherapy in patients with locally advanced cervical cancer 38
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 37
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 33
Formalin-fixed and paraffin-embedded samples for next generation sequencing: Problems and solutions 31
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 31
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 30
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 25
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 25
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 25
Safety of systemic treatments for Behçet’s syndrome 23
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 23
null 22
Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet’s disease 20
Radiomics analysis in ovarian cancer: A narrative review 20
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 18
Management of takayasu arteritis diagnosed during pregnancy: A case report 14
Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an ai approach 14
Complete Hydatidiform Mole Mimicking Sacroiliitis 13
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 12
Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI) 10
A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab 10
Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy 9
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 9
Predictors of long-term clinical remission in rheumatoid arthritis 9
Cytokine signatures in mucocutaneous and Ocular Behçet's disease 8
Efficacité de l'anakinra dans la polysérite réfractaire : étude multicentrique italienne 8
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast 7
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 7
Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study 7
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 7
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 6
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 6
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 6
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 6
COVAD survey 2 long-term outcomes: unmet need and protocol 6
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 6
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment 5
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult with Seronegative Rheumatoid Arthritis 5
Letters to the editors 5
COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence 4
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk 3
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 3
AI am a rheumatologist: A practical primer to large language models for rheumatologists 3
Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium” 3
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 3
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 2
Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF) 2
Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study 2
Unraveling the microbiome-metabolome nexus: a comprehensive study protocol for personalized management of Behḉet’s disease using explainable artificial intelligence 2
Update on the Medical Management of Gastrointestinal Behçet's Disease 1
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study 1
Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification 1
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 1
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 1
Harnessing the potential of digital rheumatology 1
Uncovering the Underworld of Axial Spondyloarthritis 1
Reply to Praprotnik and Tomsic and erratum corrige 1
Safety of abatacept in Italian patients with rheumatoid arthritis and interstitial lung disease: A multicenter retrospective study 1
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 1
Totale 1.918
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 12 16 12
2019/2020392 28 21 5 25 29 37 44 46 54 37 45 21
2020/2021324 16 26 41 10 23 29 35 39 23 34 29 19
2021/2022264 9 5 5 8 10 22 23 10 22 35 46 69
2022/2023589 48 86 32 32 41 111 13 83 92 4 33 14
2023/2024264 22 55 18 28 29 67 5 27 3 10 0 0
Totale 1.918